Detalhe da pesquisa
1.
Unraveling malignant phenotype of peritumoral tissue: transcriptomic insights into early-stage breast cancer.
Breast Cancer Res
; 26(1): 89, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38831458
2.
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells.
Br J Cancer
; 119(8): 994-1008, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30318520
3.
The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERß Ratio.
J Cell Biochem
; 117(1): 218-29, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26100284
4.
Chronic-leptin attenuates Cisplatin cytotoxicity in MCF-7 breast cancer cell line.
Cell Physiol Biochem
; 36(1): 221-32, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25967962
5.
Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio.
J Cell Biochem
; 115(5): 949-58, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24375531
6.
Metformin: From Diabetes to Cancer-Unveiling Molecular Mechanisms and Therapeutic Strategies.
Biology (Basel)
; 13(5)2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38785784
7.
The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol.
J Cell Biochem
; 113(10): 3178-85, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22615145
8.
The effects of 17ß-estradiol on mitochondrial biogenesis and function in breast cancer cell lines are dependent on the ERα/ERß ratio.
Cell Physiol Biochem
; 29(1-2): 261-8, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22415095
9.
Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast Cancer.
Cancer Res
; 82(24): 4670-4679, 2022 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36222720
10.
Vitamin D analogues exhibit antineoplastic activity in breast cancer patient-derived xenograft cells.
J Steroid Biochem Mol Biol
; 208: 105735, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32784045
11.
The Second Generation Antibody-Drug Conjugate SYD985 Overcomes Resistances to T-DM1.
Cancers (Basel)
; 12(3)2020 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32183023
12.
Resistance to the Antibody-Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity.
Cancer Res
; 77(17): 4639-4651, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28687619
13.
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition.
Mol Oncol
; 10(7): 1008-29, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27118659
14.
The presence of Estrogen Receptor ß modulates the response of breast cancer cells to therapeutic agents.
Int J Biochem Cell Biol
; 66: 85-94, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26232188
15.
UCP2 inhibition sensitizes breast cancer cells to therapeutic agents by increasing oxidative stress.
Free Radic Biol Med
; 86: 67-77, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25960046
16.
Phytoestrogens and mitochondrial biogenesis in breast cancer. Influence of estrogen receptors ratio.
Curr Pharm Des
; 20(35): 5594-618, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24606799
17.
The over-expression of ERbeta modifies estradiol effects on mitochondrial dynamics in breast cancer cell line.
Int J Biochem Cell Biol
; 45(7): 1509-15, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23618876
18.
The oxidative stress in breast tumors of postmenopausal women is ERα/ERß ratio dependent.
Free Radic Biol Med
; 61: 11-7, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23499841
19.
Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERß ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes.
Int J Biochem Cell Biol
; 45(9): 2045-51, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23871935
20.
Mitochondrial dynamics is affected by 17ß-estradiol in the MCF-7 breast cancer cell line. Effects on fusion and fission related genes.
Int J Biochem Cell Biol
; 44(11): 1901-5, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22824300